ClinicalTrials.gg
RecruitingNCT04716244Updated Apr 25, 2023

Development of Intervention for Women After Gestational Diabetes or Pre-eclampsia

An observational study in Pre-Eclampsia and Gestational Diabetes, sponsored by Hadassah Medical Organization. Recruiting at 1 site in Israel. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2023-04-25.

Sponsored by Hadassah Medical Organization · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2021; still recruiting 5 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 28 studies in Pre-Eclampsia with a site in Israel — 3 open to participants now, 3 under way, none of them phase 3. Pre-Eclampsia · Israel.

Planned enrollment
10th of 17
100 · median 150
Started
2021
the only one that year
Observational
18 of 28
1 open now
Registered
25th of 28
by date
Lead sponsor
6 of 28
Hadassah Medical Organization

Among the 28 studies in Pre-Eclampsia with a site in Israel, this one is the 10th largest by planned enrollment of the 17 observational ones that give a count, is the only one that started in 2021, is one of 18 observational ones, and was the 25th registered.

Pre-Eclampsia

918 studies on the registry are indexed under Pre-Eclampsia; 243 are open to participants now.

Browse Pre-Eclampsia studies →

Open to participants now

3 of the 28 studies in Pre-Eclampsia with a site in Israel are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →

Who these studies take

Of the 160 Pre-Eclampsia studies recruiting now, 79 (49%) set no upper age limit and 80 (50%) stop at 75 or younger; 18 take children under 18; 59 take healthy volunteers.

This study: 18 Years to 50 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Pre-Eclampsia with a site in Israel, or all of them as a file.
02

Study summary

Our objectives in this qualitative exploratory study:

  • To explore the perspectives and preferences of women with preeclampsia and/or GDM history related to a potential health promotion program
  • To identify perception of support services post-birth related to health behaviors
  • To identify perception of personal and children's risk of future health issues related to GDM and preeclampsia history
  • To explore effective intervention strategies and approaches for potential intervention
  • To identify barriers and facilitators to adoption and adherence to healthy lifestyles changes in women with preeclampsia and/or GDM history
  • Based on our results, literature review and counselling by a panel of health promotion experts, the investigators will design protocol and guidelines for a future interventional health promotion programs

Methods:

Study Design The proposed study consists of a qualitative exploratory study in different populations of women who underwent gestational diabetes or pre-eclampsia.

Health care providers who provide care to women with gestational diabetes and pre-eclampsia will be interviewed to explore effective intervention strategies.

Read the detailed description

This study aims to explore experiences, views and concerns of women with history of preeclampsia and/or GDM and gain in-depth understanding of the factors that would motivate or deter adoption and adherence to healthy lifestyle and prevention of CVD.

Our objectives in this qualitative exploratory study:

  • To explore the perspectives and preferences of women with preeclampsia and/or GDM history related to a potential health promotion program
  • To identify perception of support services post-birth related to health behaviors
  • To identify perception of personal and children's risk of future health issues related to GDM and preeclampsia history
  • To explore effective intervention strategies and approaches for potential intervention
  • To identify barriers and facilitators to adoption and adherence to healthy lifestyles changes in women with preeclampsia and/or GDM history
  • Based on our results, literature review and counselling by a panel of health promotion experts the investigators will design protocol and guidelines for a future interventional health promotion programs

Methods:

Study Design The proposed study consists of a qualitative exploratory study.

Recruitment

  1. Women aged 18-50 years following a pregnancy where they were diagnosed with preeclampsia and/or GDM will participate in this study.
  2. Health care providers who provide care to women with gestational diabetes and pre-eclampsia will be interviewed to explore effective intervention strategies.

Recruitment site 1: the investigators will conduct focus groups in Hebrew and Arabic with women after preeclampsia and/or GDM who gave birth in the Hadassah medical center or are participating in the Hadassah postpartum clinic for patients with complicated pregnancies. Separate focus groups will be conducted for women with prior preeclampsia and for women with GDM history.

The eligible women will be approached by the study investigator and will be informed about the study. The interested women will be recruited to participate in this study and will be asked to sign a consent form.

Those not able to participate in focus groups will be invited to share their experience through in-depth interviews.

Given the restrictions imposed by the Covid-19 pandemic, as well as the evidence about the difficulty among post-partum women to attend face-to-face interviews50, participants will be offered to participate in either on-site, face to face interviews in Hadassah or teleconference-based interviews (by phone or secured online meeting forms such as zoom meetings).

The investigators will ensure that the face to face groups/ interviews will be conducted in accordance with the physical-distancing instructions of the ministry of health due to Covid-19 pandemic.

The women will be contacted by the research team within 1 year from discharge. The investigators will contact them through the phone or e-mail to plan their participation in the focus groups/ in depth interviews. The interviews will take place within 12 months from the discharge.

Recruitment site 2: the investigators will recruit ultra-Orthodox (Haredi) and Arab participants through community centers from different neighborhoods in Jerusalem.

Invitation to participate in the interviews will be published using posters and/or direct contact with the women by the community-center's staff. The investigators will recruit women that participate in post-partum mothers' programs through community centers, in the Haredi and Arab neighborhoods. The eligible and interested women will be recruited to participate in the study and will be asked to sign a consent form prior to the interview. The women will sign consent before the meetings or phone consent for teleconference/ phone meetings.

Inclusion criteria/ Exclusion criteria

The investigators will recruit women:

  • Who gave birth in Hadassah medical center, Jerusalem (within 12 months of a live birth) or participating to the Hadassah postpartum clinic for patients with complicated pregnancies
  • After a pregnancy where women were diagnosed with preeclampsia and/or GDM (diagnosed) within 12 months post-partum
  • Between 18 and 50 years old
  • That will be able to communicate in Hebrew or Arabic

In the community centers, the investigators will recruit women:

  • After a pregnancy where women were diagnosed with preeclampsia and/or GDM (diagnosed) within 12 months of a live birth
  • Between 18 and 50 years old
  • That will be able to communicate in Hebrew or Arabic The investigators will exclude women with serious complications of preeclampsia and or/GDM as perinatal mortality or multi-organ failure.

The investigators will interview health care practitioners who provided health care within the Hadassah system and outside clinics.

Quantitative component:

Prior to the meetings, participants will be asked to fill in a questionnaire (will take approximately 10 minutes) . The questionnaire consists on the following sections:

Demographic data including age, family status, number of pregnancies, number of children, education, and employment History of disease: preeclampsia or GDM, family history of CVD Self -reported height and weight

Participants, who will be interviewed through tele-conference, will receive the questionnaire through electronically and will be asked to fill it prior to the interview. The questionnaire will be filled out using a participant ID which is de-identified, and will be collected through the Nemala system which is encrypted and secure according to Ministry of Health and Helsinki committee recommendations. Participants who will be unable to fill in electronically (Haredi population) will complete the questionnaire by phone. For on-site and face to face interviews, participants will be administered a print copy or the online questionnaire using a computer or tablet, using the de-identified participant identification, and will be asked to fill it prior to the interview.

Number of participants - up to 100 Focus group discussions: the investigators will conduct up to 8 groups or until the investigators reach saturation of themes. For the teleconference focus groups, the number of participants will be limited to 6 women per group, as recommended from previous research on teleconference focus groups51. The face to face focus groups will include up to -12 women. The expected duration of each group, will last 1-2 hours.

In-depth interviews: The investigators will conduct up to 36 in-depth interviews. The expected duration of each interview will last 30 minutes to -1.5 hours.

The investigators will recruit up to 100 women in total for focus groups and in-depth interviews. Each participant will be interviewed only once, in a focus group or in-depth interview, depending on her preference.

Prior to the interviews, the interviewer will explain again the purpose of the study. Interviews will be conducted by researchers from the Linda Joy Pollin center who have a previous experience conducting qualitative studies.

Participants will be asked for their consent to record the meetings, audio only. The discussions will be then transcribed without any identification information of the participants and the recordings will be destroyed afterwards. An interview guide was prepared by the research staff (see attached the interview guides- for focus groups and in-depth interviews).

To maintain confidentiality, the investigators will use first names only during the face to face/ online meeting forms -zoom meetings.

Data analysis

Focus groups and in-depth interviews will be recorded, transcribed and analyzed by investigator according to a thematic analysis:

  1. Total impression - from chaos to themes
  2. Identifying and sorting meanings units - from themes to codes
  3. Condensation - from code to meaning
  4. Synthesizing - from condensation to descriptions and concepts

Data Storage In order to maintain confidentiality, all paper data will be stored in a double locked storage space at Hadassah hospital. No identifying information will be collected on the data itself (either electronic or paper), aside from a coding number. Any documentation of focus groups/ in-depth interviews outcomes will not include identifying information.

03

Conditions studied

  • Pre-Eclampsia
  • Gestational Diabetes

Keywords

  • Pre-eclampsia
  • Gestational diabetes
  • prevention
  • health promotion
  • qualitative
  • intervention-design
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women within 12 months of gestational diabetes or pre-eclampsia

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women:

    • within 12 months of a live birth
    • After a pregnancy where women were diagnosed with preeclampsia and/or GDM (diagnosed) within 12 months post-partum
    • Between 18 and 50 years old

Exclusion criteria

Exclusion Criteria:

  • We will exclude women with serious complications of preeclampsia and or/GDM as perinatal mortality or multi-organ failure.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Gestational diabetes

    Women who were diagnosed with gestational diabetes within the least year

    Other: interview/focus group/questionnaire

  • Pre-eclampsia

    Women who were diagnosed with pre-eclampsia within the past year

    Other: interview/focus group/questionnaire

Interventions

  • Otherinterview/focus group/questionnaire

    Prior to the meetings, participants will be asked to fill in a questionnaire with demographic data including age, family status, number of pregnancies, number of children, education, and employment, history of preeclampsia or GDM, family history of CVD, and self-reported height and weight We will conduct up to 8 groups or until we reach saturation of themes. For the teleconference focus groups, the number of participants will be limited to 6 women per group, as recommended from previous research on teleconference focus groups51. The face to face focus groups will include up to -12 women. The expected duration of each group, will last 1-2 hours. We will conduct up to 36 in-depth interviews. The expected duration of each interview will last 30 minutes to -1.5 hours. Participants will be asked for their consent to record the meetings, audio only. The discussions will be then transcribed. An interview guide will be followed.

06

What researchers measure

Primary outcomes

  1. Identification of four consistent themes on thematic qualitative analysis

    Themes are general propositions that emerge from diverse and detail-rich experiences of participants and provide recurrent and unifying ideas regarding the subject of inquiry. Themes evolve from the conceptual codes and subcodes as in the case of taxonomy and also from the relationship codes, which tag data that link concepts to each other.

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Given the confidential nature of personal interviews, the de-identified thematic analysis will be made available on request of investigators with active GCP

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2021 (actual). Primary completion is estimated for Jan 2025, 47 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 10, 2021
First posted
Jan 20, 2021
StartActual
Jan 20, 2021
Primary completionEst.
Jan 1, 2025
CompletionEst.
Jul 31, 2025
Last update
Apr 25, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04716244
Responsible party
Donna R Zwas (Senior Cardiologist, Hadassah Medical Organization) — Principal investigator
First posted
Jan 20, 2021
Start date
Jan 20, 2021
Primary completion
Jan 1, 2025 (estimated)
Completion
Jul 31, 2025 (estimated)
Last update
Apr 25, 2023

Study contacts

Dvora Berdah, MPH
Contact
deborahb@hadassah.org.il
972-54-5232580
Donna Zwas, MD MPH
Contact
donnaz1818@gmail.com
972504048274
Donna Zwas, MD MPH
principal investigator · Hadassah Medical Organization

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion